tro40303
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2011 (NCT01374321)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Translocator proteinINHIBITOR
TSPO inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 3,5-seco-4-norcholestan-5-one oxime-3-ol
- tro40303
- tro40303
- tro40303
- tro 40303
- tro-40303
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01374321 | Phase 2 | Oct 1, 2011 | European Commission, Trophos, University of Oslo |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| European Commission | Government | 1 | 0 | 1 | 2011 |
| Trophos | For profit | 1 | 1 | 1 | 2011 |
| University of Oslo | Academic/Hospital | 1 | 0 | 1 | 2011 |
3 organizations
Page 1 / 1